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data set approach, with the dose distribution calculated with 
the treatment planning system used in that centre. 
Results: The gathering of IC and EPID datasets on a large 
variety of Elekta linacs went smoothly. For each linac/energy 
combination, a universal dataset was derived from similar 
linacs. This universal dataset was combined with only three 
measurements for each specific linac/energy combination: 
one IC measurement at the isocentre of a 20 cm thick 
phantom, and two EPID images, with and without the 
phantom in the beam. Preliminary validation results for 5 
linac/energy combinations and a set of square fields (3x3 to 
23x23 cm2) using the universal dataset, showed deviations of 
the dose at the iscocentre varying between -0.5% and +1.5%. 
Gamma analysis (3%/3mm) yielded values for the mean 
gamma, near-maximum gamma and gamma pass rate varying 
between 0.26-0.37, 0.67-1.04 and 96.5%-100.0%, 
respectively. These results are comparable to data obtained 
by a reconstruction from EPID measurements based on a full 
commissioning process in those centres. 
Conclusions: A generic set of EPID dosimetry model 
parameters has been derived for a variety of Elekta 
linac/energy combinations. Customizing the universal dataset 
in combination with 3 measurements instead of performing 
full commissioning decreases the amount of work needed to 
commission an EPID for dosimetry purposes by about 90% 
without a noticeable loss of accuracy. 
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Purpose/Objective: The goal of the retrospectively 
performed dose distribution simulations was to justify the 
concept of validating conformal versus intensity-modulated 
approach in the treatment of non-small cell lung cancer 
(NSCLC) patient. The insight into the difference between the 
actual (affected by respiratory motion) and planned dose 
distributions for both clinical target volume (CTV) and organs 
at risk (OARs) was provided. 
Materials and Methods: To test the influence of the 
respiratory motion on the dose distribution, for 10 patients 
representative for the spectrum of tumor sizes and locations, 
treated in free-breathing conditions (our standard 
institutional technique), 2 plans were prepared: with three-
dimensional conformal (3D-CRT) and sliding window intensity-
modulated radiation therapy (IMRT) techniques. For each of 
the field angles considered, the motion kernel (derived from 
the literature data) was generated to simulate tumor motion 
trajectories, with the largest amplitude in cranio-caudal 
direction of 4 mm, 6 mm and 8 mm repsectively. While the 
robotic platform MotionSim XY/4D with 2D diode array 
MapCHECK 2 (Sun Nuclear, USA) on it repeatedly cycled 
through the motion trajectory, radiation was delivered 
starting at a random point. The measurements’ results 
determined the agreement between the planned and 
measured doses within CTV and OARs. The evaluation of plan 
delivery was based on the Gamma Index (γ) with 3-mm 
criteria of distance to agreement (DTA) and 3% dose 
difference (ΔD).  
Results: No statistically significant differences were found 
between the motion patterns with the smallest amplitudes 
for CTV in 3DCRT plans. The differences were found for the 
8-mm amplitude when it was compared both to static 
conditions and 4-mm amplitude. For IMRT the significant 
differences between 0 mm vs. 6 mm, 0 mm vs. 8 mm and 4 
mm vs. 8 mm were found. According to the analysis 
performed for OARs, the motion impact on delivered vs. 
planned doses had less effect for esophagus and spinal cord. 
The only OARs for which the observed differences were 
comparable was heart.  
For maximal amplitudes of breathing trajectory below 4 mm 
the disagreement between planned and delivered dose 
distribution could be neglected. Whereas respiratory motion 
with amplitude above 5 mm, especially for IMRT, led to 
significant changes in delivered dose distribution. 
Conclusions: 3DCRT is safe in a greater range of respiratory 
movements amplitudes. For patients with large tumor sizes 
or due to inability of achieving proper 3DCRT dose 
distribution coming from tumor and OARs close proximity, the 
IMRT affords possibilities for further optimizing the 
therapeutic ratio. Statically planned IMRT dose distribution 
could lead to tumor underdosage due to interplay effect 
(intra-fractional motion with respect to the movement of 
MLC). It is therefore important to verify the amplitude of 
individual patient breathing motion trajectory. 
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Purpose/Objective: Craniospinal irradiation (CSI) using 
multiple isocentre intensity modulated radiation therapy 
(IMRT) allows for homogeneous dose distribution throughout 
the target and the dose distribution is conformed tightly 
around the target volume, reducing unnecessary dose to the 
organs-at-risk. The technique utilizes a combination of 
complicated field segments and there are sections of the 
treatment volume (junction) that are treated by fields from 
multiple isocenters. Small isocenter positional variations and 
dose changes in the junction regions may be unavoidable 
throughout the fractionated treatment. Dose sensitivity in 
the CSI IMRT junction region to positional and dose variations 
is tested using a diode array. 
Materials and Methods: Ten CSI patients were planned with a 
3-isocenter (cranial, upper and lower spine) IMRT technique 
using Pinnacle treatment planning system v9.2. The plans 
were prescribed to 36 Gy in 20 fractions. All beams were 
optimized simultaneously with a high weight placed on the 
target volume with lower weight placed on the other 
objectives. The isocenters were placed 25-27 cm away from 
each other. The IMRT plans were then recalculated and 
measured on a MapCHECK diode array placed in the 
upper/lower spine overlap region. ≥95% of measured to 
planned dose to the MapCHECK diodes with a γ-index <1 for 
3% dose difference and 3mm distance-to-agreement was 
deemed clinically acceptable.  
To test the sensitivity of junction region to positional and 
dose variations, the following changes were made to the plan 
